Trimming the pipeline was previously discussed as Anavex cleaned up its corporate slide deck to be focussed on those compounds and indications that are actively being worked on.
Although the Sigmaceptor platform may have and can identify further compounds, it makes sense to stay focused on those areas that will initially drive the commercial launch of the company.